Podcast Beta
Questions and Answers
What is the main evidence that lowering IOP reduces the risk of progression of POAG?
What is the current status of controlled trials for POAG?
What is necessary to help stop the progression of POAG in some patients?
Study Notes
- There is evidence that lowering IOP reduces the risk of progression of POAG (Advanced Glaucoma Intervention Study – AGIS, Early Manifest Glaucoma Trial – EMGT).
- To date, there is no controlled trials for POAG, with randomization to treatment or observation.
- A multicenter clinical trial based in the UK is under-way which will hopefully address this.
- For some POAG patients, lowering of IOP does not stop their progression.
- Searching for other reversible risk factors for POAG is essential.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
Test your knowledge about the treatment options and risk factors for primary open-angle glaucoma (POAG). Explore the evidence behind lowering intraocular pressure (IOP) and the ongoing clinical trials. Learn about the challenges in stopping disease progression and the importance of identifying reversible risk factors.
